Continuous oral cytarabine ocfosfate with interferon‐α‐2b for patients with newly diagnosed chronic myeloid leukaemia: a pilot study
MC Del Cañizo, MP Fisac, J Galende… - British journal of …, 2001 - Wiley Online Library
Recombinant® interferon α (r‐IFN‐α) has been shown to be an effective drug for chronic
myeloid leukaemia (CML). However, higher response rates can be achieved using …
myeloid leukaemia (CML). However, higher response rates can be achieved using …
Continuous oral cytarabine ocfosfate with interferon-α-2b for patients with newly diagnosed chronic myeloid leukaemia: a pilot study
MC del Canizo, MP Fisac, J Galende… - British Journal of …, 2001 - elibrary.ru
Recombinant® interferon α (r-IFN-α) has been shown to be an effective drug for chronic
myeloid leukaemia (CML). However, higher response rates can be achieved using …
myeloid leukaemia (CML). However, higher response rates can be achieved using …
Continuous oral cytarabine ocfosfate with interferon-alpha-2b for patients with newly diagnosed chronic myeloid leukaemia: a pilot study.
MC del Cañizo, MP Fisac, J Galende… - British Journal of …, 2001 - europepmc.org
Recombinant (R) interferon alpha (r-IFN-alpha) has been shown to be an effective drug for
chronic myeloid leukaemia (CML). However, higher response rates can be achieved using …
chronic myeloid leukaemia (CML). However, higher response rates can be achieved using …
[引用][C] Continuous oral cytarabine ocfosfate with interferon-α-2b for patients with newly diagnosed chronic myeloid leukaemia: a pilot study
MC DEL CANIZO, MP FISAC… - British journal of …, 2001 - pascal-francis.inist.fr
Continuous oral cytarabine ocfosfate with interferon-α-2b for patients with newly diagnosed
chronic myeloid leukaemia: a pilot study CNRS Inist Pascal-Francis CNRS Pascal and …
chronic myeloid leukaemia: a pilot study CNRS Inist Pascal-Francis CNRS Pascal and …
Continuous oral cytarabine ocfosfate with interferon-alpha-2b for patients with newly diagnosed chronic myeloid leukaemia: a pilot study
MC del Cañizo, MP Fisac, J Galende… - British journal of …, 2001 - pubmed.ncbi.nlm.nih.gov
Recombinant (R) interferon alpha (r-IFN-alpha) has been shown to be an effective drug for
chronic myeloid leukaemia (CML). However, higher response rates can be achieved using …
chronic myeloid leukaemia (CML). However, higher response rates can be achieved using …